Ensysce Biosciences Stock Probability of Future Stock Price Finishing Under 0.01
| ENSC Stock | USD 0.59 0.07 10.61% |
Ensysce |
Ensysce Biosciences Target Price Odds to finish below 0.01
The tendency of Ensysce Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.01 or more in 90 days |
| 0.59 | 90 days | 0.01 | about 1.08 |
Based on a normal probability distribution, the odds of Ensysce Biosciences to drop to $ 0.01 or more in 90 days from now is about 1.08 (This Ensysce Biosciences probability density function shows the probability of Ensysce Stock to fall within a particular range of prices over 90 days) . Probability of Ensysce Biosciences price to stay between $ 0.01 and its current price of $0.59 at the end of the 90-day period is about 85.72 .
Given the investment horizon of 90 days Ensysce Biosciences has a beta of -0.75 suggesting as returns on the benchmark increase, returns on holding Ensysce Biosciences are expected to decrease at a much lower rate. During a bear market, however, Ensysce Biosciences is likely to outperform the market. In addition to that Ensysce Biosciences has an alpha of 2.3468, implying that it can generate a 2.35 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ensysce Biosciences Price Density |
| Price |
Predictive Modules for Ensysce Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ensysce Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ensysce Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ensysce Biosciences is not an exception. The market had few large corrections towards the Ensysce Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ensysce Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ensysce Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.35 | |
β | Beta against Dow Jones | -0.75 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | 0.09 |
Ensysce Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ensysce Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ensysce Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ensysce Biosciences is way too risky over 90 days horizon | |
| Ensysce Biosciences has some characteristics of a very speculative penny stock | |
| Ensysce Biosciences appears to be risky and price may revert if volatility continues | |
| Ensysce Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Ensysce Biosciences currently holds 854.7 K in liabilities with Debt to Equity (D/E) ratio of 6.91, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Ensysce Biosciences has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Ensysce Biosciences' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 2.23 M. Net Loss for the year was (10.63 M) with loss before overhead, payroll, taxes, and interest of (1.16 M). | |
| Ensysce Biosciences currently holds about 3.15 M in cash with (10.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. | |
| Ensysce Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Ensysce Biosciences Third Quarter 2024 Earnings Beats Expectations - Yahoo Finance |
Ensysce Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ensysce Stock often depends not only on the future outlook of the current and potential Ensysce Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ensysce Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.3 M | |
| Cash And Short Term Investments | 1.1 M |
Ensysce Biosciences Technical Analysis
Ensysce Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Ensysce Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ensysce Biosciences. In general, you should focus on analyzing Ensysce Stock price patterns and their correlations with different microeconomic environments and drivers.
Ensysce Biosciences Predictive Forecast Models
Ensysce Biosciences' time-series forecasting models is one of many Ensysce Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ensysce Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ensysce Biosciences
Checking the ongoing alerts about Ensysce Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ensysce Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ensysce Biosciences is way too risky over 90 days horizon | |
| Ensysce Biosciences has some characteristics of a very speculative penny stock | |
| Ensysce Biosciences appears to be risky and price may revert if volatility continues | |
| Ensysce Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Ensysce Biosciences currently holds 854.7 K in liabilities with Debt to Equity (D/E) ratio of 6.91, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Ensysce Biosciences has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Ensysce Biosciences' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 2.23 M. Net Loss for the year was (10.63 M) with loss before overhead, payroll, taxes, and interest of (1.16 M). | |
| Ensysce Biosciences currently holds about 3.15 M in cash with (10.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. | |
| Ensysce Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Ensysce Biosciences Third Quarter 2024 Earnings Beats Expectations - Yahoo Finance |
Check out Ensysce Biosciences Backtesting, Ensysce Biosciences Valuation, Ensysce Biosciences Correlation, Ensysce Biosciences Hype Analysis, Ensysce Biosciences Volatility, Ensysce Biosciences History as well as Ensysce Biosciences Performance. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensysce Biosciences. If investors know Ensysce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensysce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.94) | Revenue Per Share 0.274 | Quarterly Revenue Growth (0.63) | Return On Assets (1.32) | Return On Equity (4.28) |
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensysce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.